Although few studies in P. falciparum phosphoethanolamine methyltransferases (PMTs)34, prolyl-tRNA synthetase (ProRS)35 and enzymes of the non-mevalonate pathway36 tried to explore the role of an allosteric inhibitor in malaria, still this approach remains challenging and yet to be characterized. The gene discussed is PARS2; the disease is malaria.